Cargando…

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates

Detalles Bibliográficos
Autores principales: Moog, C, Dereuddre-Bosquet, N, Biedma, M, Schmidt, S, Decoville, T, Mangeot, I, Zolla-Pazner, S, Vcelar, B, Katinger, D, Holl, V, Le Grand, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441560/
http://dx.doi.org/10.1186/1742-4690-9-S2-O38
_version_ 1782243318743171072
author Moog, C
Dereuddre-Bosquet, N
Biedma, M
Schmidt, S
Decoville, T
Mangeot, I
Zolla-Pazner, S
Vcelar, B
Katinger, D
Holl, V
Le Grand, R
author_facet Moog, C
Dereuddre-Bosquet, N
Biedma, M
Schmidt, S
Decoville, T
Mangeot, I
Zolla-Pazner, S
Vcelar, B
Katinger, D
Holl, V
Le Grand, R
author_sort Moog, C
collection PubMed
description
format Online
Article
Text
id pubmed-3441560
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34415602012-09-18 Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates Moog, C Dereuddre-Bosquet, N Biedma, M Schmidt, S Decoville, T Mangeot, I Zolla-Pazner, S Vcelar, B Katinger, D Holl, V Le Grand, R Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441560/ http://dx.doi.org/10.1186/1742-4690-9-S2-O38 Text en Copyright ©2012 Moog et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Moog, C
Dereuddre-Bosquet, N
Biedma, M
Schmidt, S
Decoville, T
Mangeot, I
Zolla-Pazner, S
Vcelar, B
Katinger, D
Holl, V
Le Grand, R
Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
title Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
title_full Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
title_fullStr Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
title_full_unstemmed Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
title_short Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates
title_sort non-neutralizing igg anti-pid antibodies decreased viral load following high dose vaginal challenge of non-human primates
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441560/
http://dx.doi.org/10.1186/1742-4690-9-S2-O38
work_keys_str_mv AT moogc nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT dereuddrebosquetn nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT biedmam nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT schmidts nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT decovillet nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT mangeoti nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT zollapazners nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT vcelarb nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT katingerd nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT hollv nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates
AT legrandr nonneutralizingiggantipidantibodiesdecreasedviralloadfollowinghighdosevaginalchallengeofnonhumanprimates